Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
05/2007
05/29/2007US7223593 Anticancer agents; gene coding immunomoderator cytokine protein
05/29/2007US7223591 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
05/29/2007US7223585 Viral purification methods
05/29/2007US7223543 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid
05/29/2007US7223542 Diagnosing cancer via determining concentration of marker polypeptides; genetic vaccines; antiproliferative/antitumor agents
05/29/2007US7223423 Skin-care and hair care composition of cumin, cloves, olibanum, eagle wood, and giant hyssop; cleanser, a deodorant, treating skin problems, wrinkles, skin sagging, dark spots, skin infections, skin irritation, cuts, scarring, acne, cold sores
05/29/2007US7223422 Intraarticularly injecting a fluid in the joint space of an animal; the replacement fluid is synovial fluid that has been harvested from other animals and processed to remove impurities, cellular and pathogenic components, then lyophilized, packaged and reconstituted
05/29/2007US7223391 Administering subject's modified blood on consecutive days; blood is modified extracorporeally by exposure from 2 to 5 minutes to a combination of stressors; treating ischemic stress, atherosclerosis and rheumatoid arthritis
05/29/2007US7223389 Compositions and methods for treatment of cancer
05/29/2007US7223388 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders
05/29/2007US7223346 A centrifugal spin-separator with a float in the cavity that has a density between the erythrocytes and plasma and moves through the sedimenting erythrocytes during centrifugation and releases trapped platelets
05/29/2007CA2154368C Therapeutic applications of chimeric organogenesis
05/28/2007CA2569326A1 Compositions and methods to create a vascularized environment for cellular transplantation
05/24/2007WO2007059491A2 Novel hydrogels and uses thereof
05/24/2007WO2007059431A1 Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
05/24/2007WO2007058934A2 Methods and compositions for treating basement membrane disorders
05/24/2007WO2007058404A1 Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same
05/24/2007WO2007058105A1 Method for producing pancreas from es cell
05/24/2007WO2007058027A1 Harmful bacterium control agent containing bacillus thuringiensis
05/24/2007WO2007057907A2 Device and method for cell grafting
05/24/2007WO2007057763A2 Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
05/24/2007WO2007056854A1 Method of expanding double negative t cells
05/24/2007WO2007039313A3 Probiotic enterococci for improved immunity
05/24/2007WO2007038933A3 A method for producing cells with efficient engraftment within the heart
05/24/2007WO2007034071A3 Method for preparing a sample
05/24/2007WO2007017914A3 Dermonecrotizing protein factors of bacterial origin and related uses in medical field
05/24/2007US20070117766 Vigilant cells
05/24/2007US20070117205 Hepatoblasts and method of isolating same
05/24/2007US20070117197 Lactobacilli expressing biologically active polypeptides and uses thereof
05/24/2007US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
05/24/2007US20070117180 Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme
05/24/2007US20070117142 Regulation of novel human asparagine-hydroxylases
05/24/2007US20070116779 Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease
05/24/2007US20070116778 Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases
05/24/2007US20070116750 Compositions for disrupting and inhibiting reconstitution of wound biofilm
05/24/2007US20070116698 Novel methods and medicament for treating infectious diseases involving microbial biofilms
05/24/2007US20070116693 Bacterial culture having effects of suppressing dermatitis development and accelerating skin wound healing, and product using the same
05/24/2007US20070116692 Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells
05/24/2007US20070116689 LIM mineralization protein splice variants
05/24/2007US20070116688 Methods of organ regeneration
05/24/2007US20070116686 Method for separating precursor cells producing gabaergic neuron alone
05/24/2007US20070116685 Endothelial progenitor cells that express CD31 and c-kit, and not more than one percent express Tie-2 antigen; cell therapy for eye disorders
05/24/2007US20070116684 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/24/2007US20070116683 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/24/2007US20070116682 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/24/2007US20070116681 Ex vivo and in vivo methods and related compositions for generating hematopoietic stem cell populations
05/24/2007US20070116680 Stem cells within gel microenvironments
05/24/2007US20070116679 Augmentation of organ function
05/24/2007US20070116678 Medical device with living cell sheet
05/24/2007US20070116677 administering secretoneurin intracerebrally into an affected area and the brain tissue damage is caused by cerebral ischemia or stroke; a 33-amino acid neuropeptide (TNEIVEEQYTPQSLATLESVFQELGKLTGPNNQ: SEQ ID NO: 1)
05/24/2007US20070116676 Method for three-dimensional cartilage tissue engineering using bone marrow cells in tissue engineering bone marrow cells in simulated microgravity environment
05/24/2007US20070116675 Drug and method for proliferating natural killer cells
05/24/2007US20070116674 Use of adipose tisue cells for initiating the formation of a fuctional vascular network
05/24/2007US20070116671 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
05/24/2007US20070116670 providing a medicament for the therapy of YB-1 positive diseases, in particular of tumor diseases; expressing a gene or gene fragment in a tumor cell
05/24/2007US20070113355 Composite materials
05/24/2007DE60119515T2 Probiotica für verwendung als haustierfutter Probiotics for use as petfood
05/24/2007DE202007002615U1 Badepoolanordnung mit Wasser, das mit Nano-Ozonkugeln zur Rehabilitation gefüllt ist Swimming pool arrangement with water that is filled with nano-ozone balls for rehabilitation
05/24/2007CA2629532A1 Method of expanding double negative t cells
05/24/2007CA2627974A1 Methods of treating fibrosing diseases by induction of immune tolerance
05/23/2007EP1788085A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
05/23/2007EP1787651A1 Bacterial culture having effects of suppressing dermatitis development and accelarating skin wound healing, and product using the same
05/23/2007EP1786829A1 Process for isolating biomaterial from tissue and an isolated biomaterial extract prepared therefrom
05/23/2007EP1786519A1 Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
05/23/2007EP1786485A2 Surface directed cellular attachment
05/23/2007EP1786470A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
05/23/2007EP1786456A1 Use of apo2l receptor agonists and nk cells or nk cell activators
05/23/2007EP1786445A2 Live microbial microbicides
05/23/2007EP1786444A1 Intradiscal production of autologous interleukin receptor antagonist
05/23/2007EP1786428A2 Pde5 inhibitor compositions and methods for treating cardiac indications
05/23/2007EP1786273A2 Sequential protein isolation and purirication schemes by affinity chromatography
05/23/2007EP1307537B1 Neospora caninum isolate
05/23/2007EP1177157B1 A vital matter and a producing method
05/23/2007EP1175221B1 Lactic acid bacteria with anxiolytic properties and uses thereof
05/23/2007EP0820469B1 Identification, purification and uses of leczymes and carbohydrate ligands
05/23/2007CN1969040A Method for making high purity cardiomyocyte preparations suitable for regenerative medicine
05/23/2007CN1969039A Tissue material and muscle derived matrix
05/23/2007CN1968959A 流行性感冒治疗 Influenza treatment
05/23/2007CN1968608A Improved modalities for the treatment of degenerative diseases of the retina
05/23/2007CN1966684A Construction of HER2/neu mRNA in vitro transcription vector and use thereof
05/23/2007CN1966675A Non-human mammal embryonic tissue cell suitable for cell transplantation, its preparation method and application
05/23/2007CN1966068A Transfer factor solution containing cluster water used for animals
05/23/2007CN1966067A Medicament for treating aplastic anemia
05/23/2007CN1966065A Chinese herbal pill for treating hepatitis B
05/23/2007CN1966062A Medicinal decoction for treating urticaria occurred in menstrual period and preparation process thereof
05/23/2007CN1966060A Drink for protecting wrist
05/23/2007CN1966059A Drink for treating bone fracture
05/23/2007CN1966058A Drink for preventing miscarriage
05/23/2007CN1966057A Externally applied Chinese medicinal liquid for preventing and treating chilblain
05/23/2007CN1966055A Medicament for treating chronic bronchitis and preparation method thereof
05/23/2007CN1966053A Medicament for removing freckles
05/23/2007CN1966050A Medicament for treating heart disease and preparation process thereof
05/23/2007CN1966049A Medicinal decoction for treating liver constraint restraining spleen type amenorrhvea
05/23/2007CN1966048A Chinese medicinal formulation for treating apoplexy sequelae
05/23/2007CN1966043A Externally applied medicament for treating hyperplasia of mammary glands and preparation method thereof
05/23/2007CN1966042A Externally applied ointment for treating hyperosteogeny and preparation method thereof
05/23/2007CN1966041A Chinese medicinal formulation for treating depression
05/23/2007CN1966040A Chinese medicinal decoction for treating gastrointestinal diseases
05/23/2007CN1966036A Chinese medicine for treating gastrointestinal disease and preparation method thereof
05/23/2007CN1966035A Chinese medicinal formulation for treating children's hyperkinetic syndrome